German Federal Minister of Economic Cooperation and Development Tours Vetter

Ravensburg, Germany, February 14, 2011 / b3c newswire / – Dirk Niebel, Germany’s Federal Minister for Economic Cooperation and Development, stopped today at Vetter’s Ravensburg Vetter South facility during a regional tour. Vetter is an independent international specialist in the aseptic filling of drug-delivery systems. "Innovative, mid-sized companies like Vetter are not only an important engine of the German economy," said Niebel, “but as successful international players, they make a noteworthy contribution to the development of the global pharmaceutical market."

Vetter, whose staff numbers 2,300 in Europe and the United States, works with the world´s leading pharmaceutical and biotech companies. The service provider fills syringes, cartridges and vials with innovative drugs that treat a range of diseases, including cancer, multiple sclerosis and rheumatoid arthritis. Niebel toured the company’s Ravensburg Vetter South, which is considered one of the most advanced manufacturing facilities in the world. In 2007, the year it began operations, the production site received the “Facility of the Year Award” for process innovation and the “European Outsourcing Award” as most improved process/plant/facility.

"We are pleased to receive a high-level visit from Germany´s capital," said Udo J. Vetter, partner and chairman of the company’s advisory board. "We have grown steadily since our founding and are among the leading providers in our segment. A visit by Federal Minister Niebel underscores that a family-run mid-sized company can be a successful global player."

About Vetter - www.vetter-pharma.com

Vetter is an independent international specialist in the aseptic filling of syringes, cartridges and vials. The company has extensive experience with a broad array of substances, including monoclonal antibodies, peptides, interferons and vaccines. Headquartered in Ravensburg, Germany, Vetter provides support for pharmaceutical and biotech clients from preclinical development through regulatory approval and global market supply. Vetter’s new Chicago facility, an expansion of Vetter Development Service, supports early-stage products. The firm works with the world’s leading pharmaceutical and biotech companies and employs 2,300 staff across Europe and the United States. The innovator of the Vetter Lyo-Ject® dual-chamber syringe and V-LK® cartridge, the company holds nearly 140 patents and is a leader in the use of RABS technology in cleanrooms. Approved as a foreign manufacturer by the government of Japan , Vetter’s global regulatory experience includes numerous customer product approvals by the FDA, EMA and other authorities. Over its more than 25-year history in aseptic filling, Vetter has won many awards for its facilities and operations, including the 2009 Axia Award for customer relationship management and the 2010 SAP EMEA Quality Award, silver medal, for the implementation of a companywide planning software system.

For more information contact:

Vetter Pharma International GmbH Oskar Gold Eywiesenstrasse 5 88212 Ravensburg Germany phone: +49-(0)751-3700-3729 fax: +49-(0)751-3700-7707 e-mail: press@vetter-pharma.com www.vetter-pharma.com